EspeRare presented the “Development of Rimeporide, a selective sodium-hydrogen exchanger inhibitor, for Patient with Duchenne Muscular Dystrophy” at the 13th International Congress on Neuromuscular Diseases in Nice from the 5-10th of July 2014.
Click on picture to view
For more information on the ICNMD congress click here
